“Collapsing pharmaceutical investment in a disease of global concern such as TB is alarming,” said Colleen Daniels, TAG’s TB/HIV project director. “Public and charitable institutions have matched and exceeded investments made by pharmaceutical companies in their own products, but it hasn’t been enough to keep industry involved. The current R&D model is broken and is failing TB patients, who have had to wait decades for better diagnostics, drugs, and vaccines to fight TB.”
Barbara Glickstein hosts this week’s Healthstyles on WBAI Pacifica Radion 99.5 FM streamed at www.wbai.org at 1PM to 2PM.
She opens with HealthCetera:
Hear her interview with Colleen A. Daniels, the Director of TB/HIV Project with the Treatment Action Group, an independent AIDS research and policy think tank fighting for better treatment, a vaccine, and a cure for AIDS and its two major coinfections, TB and hepatitis C. She reports on the findings of the 2014 Report on Tuberculosis Research Funding Trends, 2005-2013.
In the second part of the hour she celebrates the first anniversary of FireceforBlackWomen.com‘s with co-founders Yanick Rice Lamb and Sheree Crute.
This week’s Healthstyles ends with the first of a series of readings from the live recording of “The Bedpan Confessionals: Tall Tales of Truth By Nurses, For Everyone”.
Listen to the series here: